Editorial: Establishing Genetic Pleiotropy to Identify Common Pharmacological Agents for Common Diseases
Main Authors: | Tracy A. O’Mara, Jyotsna Batra, Dylan Glubb |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.01038/full |
Similar Items
-
Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer
by: Siddhartha P. Kar, et al.
Published: (2021-07-01) -
HOPS: a quantitative score reveals pervasive horizontal pleiotropy in human genetic variation is driven by extreme polygenicity of human traits and diseases
by: Daniel M. Jordan, et al.
Published: (2019-10-01) -
Implications of pleiotropy: Challenges and opportunities for mining Big Data in Biomedicine
by: Can eYang, et al.
Published: (2015-06-01) -
Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
by: Ali Khosravi, et al.
Published: (2019-06-01) -
Enhancing the Promise of Drug Repositioning through Genetics
by: Jayne-Louise E. Pritchard, et al.
Published: (2017-12-01)